New Use of Long-Acting Bronchodilators in COPD Tied to Increased Cardiovascular Risk

Patients with chronic obstructive pulmonary disease who begin treatment with a long-acting beta agonist (LABA) or long-acting muscarinic antagonist (LAMA) face significantly increased...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news